Neuromuscular-blocking agents (NMBAs) allow for surgical procedures that would be difficult or impossible without induced paralysis. In this issue of Anesthesiology, McLean and his colleagues demonstrate a dose-dependent association between intermediate-acting NMBAs and postoperative respiratory complications. In an accompanying Editorial View, Brull and Prielipp make a plea to all clinicians: to reduce complications, use objective measurement of neuromuscular function in all patients receiving NMBAs to guide the timing and dosing of neuromuscular blockade and its reversal.

  • McLean et al.: Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications, p. 1201

  • Brull and Prielipp: Reversal of Neuromuscular Blockade: “Identification Friend or Foe,” p. 1183